Levens W J, Fischer N, Ingehag W, Rubben H
Department of Urology, University Clinic, Aachen, Federal Republic of Germany.
Semin Surg Oncol. 1988;4(3):204-6. doi: 10.1002/ssu.2980040313.
Adverse reactions in interferon treatment were studied in long-term treatment schedules. Thirteen patients with metastatic renal cell carcinoma treated with 10(7) units interferon-2b s.c. daily for 6 months showed serious side effects. The general condition worsened in 10 patients. The average weight loss was 7 kg per patient. The remissions achieved (1 complete, 2 partial) were seen after 2-3 months of treatment. In 11 patients treated in an adjunctive setting (10(7) units interferon-2b s.c. 3 times weekly) side effects were less severe. Generally the treatment was tolerated well. In one patient the general condition worsened, weight loss was mild and restricted to the first treatment month.
在长期治疗方案中研究了干扰素治疗的不良反应。13例转移性肾细胞癌患者,每天皮下注射10⁷单位干扰素-2b,持续6个月,出现了严重的副作用。10例患者的总体状况恶化。每位患者平均体重减轻7千克。治疗2 - 3个月后出现缓解(1例完全缓解,2例部分缓解)。11例辅助治疗的患者(每周皮下注射10⁷单位干扰素-2b,共3次)副作用较轻。总体而言,治疗耐受性良好。1例患者的总体状况恶化,体重减轻轻微,且仅限于第一个治疗月。